Ginger Gregory - Biogen Ex Officer
| IDP Stock | 151.80 2.25 1.50% |
Executive
Ginger Gregory is Ex Officer of Biogen Inc
| Age | 55 |
| Phone | 617 679 2000 |
| Web | https://www.biogen.com |
Ginger Gregory Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ginger Gregory against Biogen stock is an integral part of due diligence when investing in Biogen. Ginger Gregory insider activity provides valuable insight into whether Biogen is net buyers or sellers over its current business cycle. Note, Biogen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Biogen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ginger Gregory over six months ago Disposition of 634 shares by Ginger Gregory of Biogen at 240.98 subject to Rule 16b-3 |
Biogen Management Efficiency
The company has return on total asset (ROA) of 0.0778 % which means that it generated a profit of $0.0778 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2433 %, meaning that it generated $0.2433 on every $100 dollars invested by stockholders. Biogen's management efficiency ratios could be used to measure how well Biogen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | EXECUTIVE Age | ||
| Nancy Grygiel | Amgen Inc | 55 | |
| Esteban Santos | Amgen Inc | 55 | |
| Johanna Mercier | General Mills | 53 | |
| Murdo Gordon | Amgen Inc | 56 | |
| David MD | Amgen Inc | 60 | |
| Deborah Telman | General Mills | 58 | |
| Jyoti Mehra | General Mills | 47 | |
Management Performance
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0778 |
Biogen Inc Leadership Team
Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Viehbacher, CEO Pres | ||
| Robin Kramer, VP Officer | ||
| Sanjay Jariwala, VP Medical | ||
| Ginger Gregory, Ex Officer | ||
| Anabella Villalobos, Head Sciences | ||
| Susan Esq, Chief VP | ||
| Michael CPA, Ex CFO | ||
| Natacha Gassenbach, Chief Affairs | ||
| Nicole Murphy, Head Technology | ||
| Michael Hencke, Head Relations |
Biogen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Biogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.24 | |||
| Return On Asset | 0.0778 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 41.13 B | |||
| Shares Outstanding | 144.49 M | |||
| Shares Owned By Insiders | 0.68 % | |||
| Shares Owned By Institutions | 89.97 % | |||
| Price To Book | 3.26 X | |||
| Price To Sales | 3.77 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biogen Stock Analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.